Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors: supplementary presentation

S S L Goh; P S M Lai; A T B Tan; S Ponnampalavanar

doi:10.1007/s00198-018-4379-y

Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors: supplementary presentation

Osteoporos Int. 2018 Jul;29(7):1683. doi: 10.1007/s00198-018-4379-y. Epub 2018 May 8.

Authors

S S L Goh¹, P S M Lai², A T B Tan³, S Ponnampalavanar⁴

Affiliations

¹ Department of Primary Care Medicine, University of Malaya Primary Care Research Group, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
² Department of Primary Care Medicine, University of Malaya Primary Care Research Group, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. [email protected].
³ Department of Medicine (Endocrine), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
⁴ Department of Medicine (Infectious Disease), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

PMID: 29737369
DOI: 10.1007/s00198-018-4379-y

Abstract

A meta-analysis was conducted to evaluate the prevalence of osteopenia/osteoporosis in human immunodeficiency virus (HIV)-infected individuals. The prevalence of osteopenia/osteoporosis in HIV-infected and antiretroviral therapy (ART)-treated individuals was significantly higher than respective controls. Evidence regarding bone loss within first year of HIV infection or ART initiation was preliminary.

Keywords: Antiretroviral therapy; Bone density; HIV; Osteopenia; Osteoporosis.

Publication types

Editorial

Grants and funding

H-20001-00-E000091/University of Malaya High Impact Research Grants/International